|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
5,560,000,000 |
Market
Cap: |
134.89(B) |
Last
Volume: |
25,595,735 |
Avg
Vol: |
32,466,410 |
52
Week Range: |
$21.59 - $31.39 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
DOW JONES COMPOSITE |
|
DOW JONES INDUSTRIAL AVERAGE |
|
NYSE COMPOSITE |
|
S&P 100 |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 9.9 |
Insider 3/6 Months : 10.5 |
|
Guru Rank Number : 223 |
Guru Rank Value : 7 |
Guru Occurances : 4 |
|
|
|
|
|
|
|
Company Profile Pfizer is a research-based biopharmaceutical company. Co. is engaged in the discovering, developing, manufacturing, marketing, sales and distribution of biopharmaceutical products. Co.'s business includes: internal medicine, which includes cardiovascular metabolic and pain products; oncology, which includes products in biologics, small molecules, immunotherapies, and biosimilars for cancers; hospital, which includes Co.'s portfolio of sterile injectable and anti-infective medicines, as well as Pfizer CentreOne; vaccines, which includes vaccines brands in pneumococcal disease, meningococcal disease, tick-borne encephalitis and COVID-19; inflammation and immunology; and rare disease.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
19,457 |
20,457 |
23,457 |
Total Buy Value |
$0 |
$499,072 |
$527,312 |
$606,713 |
Total People Bought |
0 |
1 |
2 |
2 |
Total Buy Transactions |
0 |
1 |
2 |
3 |
Total Shares Sold |
0 |
2,500 |
7,654 |
7,654 |
Total Sell Value |
$0 |
$64,825 |
$212,539 |
$212,539 |
Total People Sold |
0 |
1 |
1 |
1 |
Total Sell Transactions |
0 |
1 |
2 |
2 |
End Date |
2025-03-27 |
2024-12-24 |
2024-06-25 |
2023-06-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Damico Jennifer B. |
SVP & Controller |
|
2025-03-04 |
4 |
S |
$25.93 |
$64,825 |
D/D |
(2,500) |
11,850 |
|
6% |
|
Damico Jennifer B. |
SVP & Controller |
|
2025-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
5,583 |
14,350 |
|
- |
|
Damico Jennifer B. |
SVP & Controller |
|
2025-02-27 |
4 |
D |
$26.10 |
$19,549 |
D/D |
(749) |
29,761 |
|
- |
|
Damico Jennifer B. |
SVP & Controller |
|
2025-02-27 |
4 |
D |
$26.06 |
$561,537 |
D/D |
(21,547) |
9,516 |
|
- |
|
Damico Jennifer B. |
SVP & Controller |
|
2025-02-27 |
4 |
OE |
$31.31 |
$701,845 |
D/D |
22,416 |
31,063 |
|
- |
|
Bourla Albert |
Chairman & CEO |
|
2025-02-27 |
4 |
D |
$26.06 |
$14,702,611 |
D/D |
(564,155) |
367,589 |
|
- |
|
Bourla Albert |
Chairman & CEO |
|
2025-02-27 |
4 |
OE |
$31.31 |
$18,248,188 |
D/D |
582,823 |
931,744 |
|
- |
|
Lankler Douglas M |
Executive Vice President |
|
2025-02-27 |
4 |
D |
$26.06 |
$3,923,477 |
D/D |
(150,550) |
159,240 |
|
- |
|
Lankler Douglas M |
Executive Vice President |
|
2025-02-27 |
4 |
OE |
$31.31 |
$4,912,977 |
D/D |
156,914 |
309,790 |
|
- |
|
Susman Sally |
Executive Vice President |
|
2025-02-27 |
4 |
D |
$26.06 |
$2,135,887 |
D/D |
(81,957) |
168,909 |
|
- |
|
Susman Sally |
Executive Vice President |
|
2025-02-27 |
4 |
OE |
$31.31 |
$2,667,048 |
D/D |
85,182 |
250,866 |
|
- |
|
Mcdermott Michael |
Executive Vice President |
|
2025-02-27 |
4 |
D |
$26.06 |
$1,210,662 |
D/D |
(46,455) |
75,958 |
|
- |
|
Mcdermott Michael |
Executive Vice President |
|
2025-02-27 |
4 |
OE |
$31.31 |
$1,515,999 |
D/D |
48,419 |
122,413 |
|
- |
|
Fonseca Lidia |
Executive Vice President |
|
2025-02-27 |
4 |
D |
$26.06 |
$1,816,580 |
D/D |
(69,705) |
41,829 |
|
- |
|
Fonseca Lidia |
Executive Vice President |
|
2025-02-27 |
4 |
OE |
$31.31 |
$2,274,014 |
D/D |
72,629 |
111,534 |
|
- |
|
Sahni Payal |
Executive Vice President |
|
2025-02-27 |
4 |
D |
$26.06 |
$477,282 |
D/D |
(18,314) |
25,928 |
|
- |
|
Sahni Payal |
Executive Vice President |
|
2025-02-27 |
4 |
OE |
$31.31 |
$596,581 |
D/D |
19,054 |
44,242 |
|
- |
|
Boshoff Christoffel |
President, R&D |
|
2025-02-27 |
4 |
D |
$26.10 |
$232,525 |
D/D |
(8,909) |
163,238 |
|
- |
|
Boshoff Christoffel |
President, R&D |
|
2025-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
17,450 |
172,147 |
|
- |
|
Boshoff Christoffel |
President, R&D |
|
2025-02-26 |
4 |
D |
$26.42 |
$128,718 |
D/D |
(4,872) |
155,100 |
|
- |
|
Boshoff Christoffel |
President, R&D |
|
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
9,687 |
159,972 |
|
- |
|
Mcdermott Michael |
Executive Vice President |
|
2025-02-26 |
4 |
D |
$26.42 |
$85,072 |
D/D |
(3,220) |
73,994 |
|
- |
|
Damico Jennifer B. |
SVP & Controller |
|
2025-02-24 |
4/A |
D |
$26.65 |
$10,047 |
D/D |
(377) |
8,647 |
|
- |
|
Boshoff Christoffel |
President, R&D |
|
2025-02-24 |
4/A |
D |
$26.65 |
$10,740 |
D/D |
(403) |
149,882 |
|
- |
|
Boshoff Christoffel |
President, R&D |
|
2025-02-23 |
4 |
D |
$26.30 |
$17,411 |
D/D |
(662) |
150,285 |
|
- |
|
658 Records found
|
|
Page 1 of 27 |
|
|